Franchise winners prove that not only big is beautiful
This article was originally published in Clinica
Executive Summary
The past year proved to be volatile and difficult for US medical device stocks, with only large capitalisation companies performing particularly well. Carol Winslow takes a close look at developments and assesses the factors that will shape the market in 1998.